Literature DB >> 17725457

[Hemoperfusion in the treatment of acute valproic acid intoxication].

R Peces1, E J Fernández, R J Sánchez, C Peces, A Montero, R Selgas.   

Abstract

Valproic acid is increasingly used in the treatment of epilepsy, and also prescribed for bipolar affective disorders, schizoaffective disorders, schizophrenia and migraine prophylaxis. Valproic acid intoxication with suicide attempt is a relatively common clinical problem that can result in coma, respiratory depression, pancytopenia, hemodynamic instability and death. The drug's relatively low molecular weight, small volume of distribution and saturable protein-binding render it potentially amenable to exracorporeal removal (hemodialysis, hemoperfusion or hemofiltration ), but published experience is scarce. We describe a case report involving valproic acid intoxication with ingestion of ethanol, who was successfully treated with charcoal hemoperfusion. With this treatment the half-life of valproic acid was reduced with rapid lowering of valproic acid levels and clinical improvement. Based on our experience in this patient and a review of previously reported cases, charcoal hemoperfusion should be considered for serious valproic acid intoxication because free as well as bound drug fractions are eliminated via this technique.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17725457

Source DB:  PubMed          Journal:  Nefrologia        ISSN: 0211-6995            Impact factor:   2.033


  2 in total

1.  Overdose with antiepileptic drugs: the efficacy of extracorporeal removal techniques.

Authors:  Rita Moinho; Andrea Dias; Paula Estanqueiro; José Farela Neves
Journal:  BMJ Case Rep       Date:  2014-11-24

2.  High-flux hemodialysis and levocarnitine in the treatment of severe valproic Acid intoxication.

Authors:  V Temel; Müge Arikan; G Temel
Journal:  Case Rep Emerg Med       Date:  2013-05-21
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.